Literature DB >> 9709897

An open-label pilot study of the efficacy and tolerability of once-daily didanosine versus twice-daily didanosine.

P Keiser1, D Turner, O Ramilo, M B Kvanli, J W Smith, N Nassar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9709897     DOI： 10.1086/517700

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  3 in total

Review 1.  Didanosine: an updated review of its use in HIV infection.

Authors:  C M Perry; S Noble
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

2.  Bioavailability of once- and twice-daily regimens of didanosine in human immunodeficiency virus-infected children.

Authors:  T Abreu; K Plaisance; V Rexroad; S Nogueira; R H Oliveira; L A Evangelista; R Rangel; I S Silva; C Knupp; J S Lambert
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

Review 3.  Pharmacokinetics of antiretroviral therapy in HIV-1-infected children.

Authors:  Pieter L A Fraaij; Jeroen J A van Kampen; David M Burger; Ronald de Groot
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.